|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer显示文摘 | Thrall MM Gray HJ Symons RG | 2011 | Gynecol Oncol2011，123，3： | 1 |
| 2 | Hepatic microsomal drug metabolism in the pregnant rat显示文摘 | Symons AM Turcan RG Parke DV | 1982 | Xenobiotica1982，12，6： | 1 |
| 3 | Drug metabolism,cytochrome P450 spin state,and phospholipid changes during pregnancy in the rat显示文摘 | Turcan RG Tamburini PP Gibson GG Parke DV Symons AM | 1981 | Biochem Pharmacol1981，30，11： | 1 |
| 4 | Risk tolerance and bile duct injury: surgeon characteristics, risk taking preference, and common bile duct injuries显示文摘 | Massarweh NN Devlin A Symons RG | 2009 | J Am Coll Surg2009，209，1： | 1 |
| 5 | Management of pleural space infections: a population - based analysis 显示文摘 | Farjah F Symons RG Krishnadasan B | 2007 | J Thorac Cardiovasc Surg2007，133，2： | 1 |
| 6 | Risk tolerance and bile duct injury:surgeon characteristics,risk-taking preference,and common bile duct injuries显示文摘 | Massarweh NN Devlin A Symons RG | | 0，，01： | 1 |
| 7 | Managment of pletual space infections: a population-based analysis显示文摘 | Farjah F Symons RG Krishnadasan B etal | 2007 | J Thorac Cardiovase Surg2007，133，： | 1 |
| 8 | Risk tol- erance and bile duct injury: surgeon characteristics, risk - taking preference, and common bile duct injuries 显示文摘 | MASSARWEH NN DEVLIN A SYMONS RG | 2009 | J Am Coil Surg2009，209，1： | 1 |
| 9 | A survey of cardiopulmonary bypass perfuaJon practices in Australia in 1992 显示文摘 | Wajon PR Walsh RG Symons NL | 1993 | Anaesth In- tensive Care1993，21，6： | 1 |
| 10 | Managment of pletual space infections: a population-based analysis 显示文摘 | Furjah F Symons RG Krishnadasan B | 2007 | J Thorac Cardiovasc Surg2007，133，2： | 1 |
| 11 | Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer显示文摘 | Thrall MM Gray HJ Symons RG | 2011 | Gynecol Oncol2011，123，3： | 1 |
| 12 | Managment of pletual space infections:a population-based analysis显示文摘 | Farjah F Symons RG Krishnadasan B | 2007 | J Thorac Cardiovasc Surg2007，133，2： | 1 |
| 13 | Lower extremity angioplasty for claudication : a population- level analysis of 30 day outcomes显示文摘 | Vogel TR Su LT Symons RG st al | 2007 | J Vasc Surg2007，45，4： | 1 |
| 14 | A rat model of the ^131Ⅰ - induced changes in thyroid function显示文摘 | Reilly CP Symons RG Wellby ML | 1986 | J Endocrinol Invest1986，9，5： | 1 |
| 15 | Perioperative hyperglyeemia and risk of adverse events among patients with and without diabetes显示文摘 | KOTAGAL M SYMONS RG HIRSCH IB | 2015 | Ann Surg2015，261，1： | 1 |
| 16 | An essential role for Rac in Ras transformation显示文摘 | Qiu RG Chen J Kim D McCormick F Symons M | 1995 | Nature1995，374，： | 1 |
| 17 | Perioperative Hypergly- cemia and Risk of Adverse events among patients with and without diabetes 显示文摘 | Kotagal M Symons RG I-lirsch IB | 2015 | Ann Surg2015，261，1： | 1 |
| 18 | Risk toleranceand bile duct injures 显示文摘 | Massarweh NN Devlin A Symons RG | 2009 | Am Coll Surg2009，209，1： | 1 |
| 19 | Management of pleural space infections:a population based analysis显示文摘 | Farjah F Symons RG Krishnadasan B | 2007 | J Thorac Cardiovasc Surg2007，133，2： | 1 |
| 20 | Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy显示文摘AIM:To investigate perioperative patient morbidity/mortality and outcome after cytoreductive surgery(CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC).METHODS:Of 150 patients 100 were treated with cytoreductive surgery and HIPEC and retrospectively analyzed.Clinical and postoperative follow-up data were evaluated.Body mass index(BMI),age and peritoneal carcinomatosis index(PCI) were chosen as selection criteria with regard to tumor-free survival and perioperative morbidity for this multimodal therapy.RESULTS:CRS with HIPEC was successfully performed in 100 out of 150 patients.Fifty patients were excluded because of intraoperative contraindication.Median PCI was 17(1-39).In 89% a radical resection(CC0/CC1) was achieved.One patient died postoperatively due to multiorgan failure.Neither PCI,age nor BMI was a risk factor for postoperative complications/outcome according to the DINDO classification.In 9% Re-CRS with HIPEC was performed during the follow-up period.CONCLUSION:Patient selection remains the most important issue.Neither PCI,age nor BMI alone should be an exclusion criterion for this multimodal therapy. | Ingmar Knigsrainer Derek Zieker Jrg Glatzle Olivia Lauk Julia Klimek Stephan Symons Bjrn Brücher Stefan Beckert Alfred Knigsrainer | 2012 | World Journal of Gastroenterology2012，18，17： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员